Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic sclerosis.

V D Steen1

  • 1Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania.

Rheumatic Diseases Clinics of North America
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis (SSc) predominantly affects women and older individuals, with a higher incidence in young black women. Early identification and treatment, such as ACE inhibitors for renal crisis, can improve survival in this complex, multi-organ disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SYSTEMIC SCLEROSIS RELATED CALCINOSIS: PATIENTS PROVIDE WHAT SPECIALISTS WANT TO LEARN.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2016
Same author

Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.

Clinical and experimental rheumatology·2014
Same author

Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative.

Clinical and experimental rheumatology·2013
Same author

Is exercise-induced pulmonary hypertension ready for prime time in systemic sclerosis?

International journal of clinical practice. Supplement·2010
Same author

Development of a provisional core set of response measures for clinical trials of systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.

Annals of the rheumatic diseases·2006
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Rheumatology
  • Epidemiology
  • Immunology

Background:

  • Systemic sclerosis (SSc) is a chronic autoimmune disease with diverse clinical manifestations.
  • It disproportionately affects women, particularly during childbearing years, and shows increased incidence with age.
  • While genetic factors play a minor role, occupational exposures may contribute to SSc pathogenesis.

Purpose of the Study:

  • To summarize the key epidemiological features of systemic sclerosis.
  • To highlight the impact of SSc on lifespan and survival.
  • To underscore the importance of targeted research for better understanding and management.

Main Methods:

  • Review of existing epidemiological data on SSc.
  • Analysis of demographic trends, including age, sex, and race.

Related Experiment Videos

  • Examination of factors influencing disease pathogenesis and survival.

    • Main Results:

    • SSc incidence rises with age and is more common in women, especially young black women.
    • The disease significantly reduces lifespan due to multi-organ involvement.
    • ACE inhibitors have dramatically improved survival rates for SSc-associated renal crisis.

    Conclusions:

    • Systemic sclerosis exhibits distinct demographic patterns and risk factors.
    • Effective management of complications like renal crisis can improve patient outcomes.
    • Further research focusing on homogeneous patient subsets is crucial for advancing SSc understanding and treatment.